Bard Surgical Mesh Settlement Results in $60M Payment To States

Becton Dickinsonโ€™s C.R. Bard unit has agreed to pay $60 million to settle surgical mesh lawsuits filed by 48 U.S. states over the company’s marketing of certain transvaginal products, which have caused thousands of women nationwide wide to suffer severe and debilitating injuries in recent years.

The pelvic mesh settlement comes after the company has paid millions to resolve individual injury claims, as part of a massive litigation that included more than 100,000 product liability lawsuits brought over problems with surgical mesh sold by Bard, Ethicon, Boston Scientific and other companies.

On September 24, a number of state attorneys general issued press releases announcing the deal between C.R. Bard, Inc. and a bipartisan group of attorneys general, who say the company engaged in deceptive marketing practices to push its transvaginal mesh products.

|
|

The attorneys general accused the manufacturer of misrepresenting or failing to adequately disclose serious health risks linked to the vaginal mesh implants, including the risk of chronic pain, scarring, infections, erosion of the mesh through the vaginal walls and other complications.

While agreeing to the settlement, Bard has refused to admit wrongdoing. Last year, Johnson & Johnson reached a similar settlement, paying out $117 million to resolve lawsuits filed by 41 states.

In April 2019, the FDA announced that it was removing all remaining transvaginal mesh products from the market, after finding that manufacturers failed to establish that they are safe or effective.

โ€œC. R. Bard sold these transvaginal surgical mesh devices, knowing that they could have serious, permanent side effects,โ€ Illinois Attorney General Kwame Raoul said in a September 24 press release. โ€œThe companyโ€™s actions caused women to experience painful and life-changing medical issues. Todayโ€™s settlement holds C.R. Bard and its parent company accountable and ensures that any future patients are better informed about the use of surgical mesh products.โ€

The surgical mesh settlement resolves claims filed by Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington and Wisconsin.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Abbott Laboratories faces a lawsuit from a North Carolina woman who says sales representatives repeatedly tried to reprogram a spinal cord stimulator that had already failed due to other problems.
Both Abbott Laboratories and Boston Scientific are fighting against a call by plaintiffs to consolidate all spinal cord stimulator lawsuits before one federal judge for pretrial proceedings.